Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Clinical outcome of adding long-acting β-agonists to inhaled corticosteroids — Peter J Barnes (2001) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Clinical outcome of adding long-acting β-agonists to inhaled corticosteroids
Shared by
Peter J Barnes
Imperial College London
Clinical outcome of adding long-acting β-agonists to inhaled corticosteroids
Article
2001
en
Related publications
Article
2008
Increasing Doses of Inhaled Corticosteroids Compared to Adding Long-Acting Inhaled β 2 -Agonists in Achieving Asthma Control
Paul M. O’Byrne
,
Ian Naya
,
Anders Källén
,
Dirkje S. Postma
,
Peter J Barnes
Article
2002
Scientific rationale for inhaled combination therapy with long-acting β<sub>2</sub>-agonists and corticosteroids
Peter J Barnes
Authors
Peter J Barnes
Imperial College London
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Article
2012
An In Vitro Monocyte Washout Model To Determine Molecular Differences Between Short And Long-Acting Inhaled Corticosteroids (ICS)
Amir Hakim
,
Malcolm Johnson
,
Peter J Barnes
,
Ian M. Adcock
,
Omar S. Usmani
Article
1997
Effect of short- and long-acting inhaled beta2-agonists on exhaled nitric oxide in asthmatic patients
DH Yates
,
SA Kharitonov
,
Peter J Barnes
Article
2013
Inhaled long-acting β2 agonists enhance glucocorticoid receptor nuclear translocation and efficacy in sputum macrophages in COPD
Rubaiyat Haque
,
Amir Hakim
,
Thunicia Moodley
,
Alfonso Torrego
,
Sarah Essilfie-Quaye
,
Elen Jazrawi
,
Malcolm Johnson
,
Peter J Barnes
,
Ian M. Adcock
,
Omar S. Usmani
Discussion(0)
No comments yet. Be the first to comment.